banner
Home / Blog / Overcoming the Challenges of Gene Therapy
Blog

Overcoming the Challenges of Gene Therapy

May 17, 2023May 17, 2023

Despite research efforts and numerous ongoing clinical trials, there are only two FDA-approved adeno-associated virus (AAV) gene therapies available. Transitioning gene therapies from the laboratory bench to the clinic entails multiple considerations, including vector optimization, manufacturing, and safety. In this seminar, Dawn Bowles, Samira Kiani, David Schaffer, and Weidong Xiao will discuss the challenges of developing gene therapies and novel strategies to make AAV gene therapies safer and more effective.

Topics to be covered

Thursday, June 29th, 2023 | 1:30 PM - 4:00 PM Eastern TimeThis seminar will be available to view live and on demand.

Speakers

Dawn Bowles, PhD

Assistant professorDuke University

Samira Kiani, MD, PhD

Associate ProfessorUniversity of Pittsburgh

David Schaffer, PhD

Hubbard Howe Jr. Distinguished ProfessorUniversity of California at Berkeley

Weidong Xiao, PhD

ProfessorIndiana University

The information you provide will be shared with the sponsors of this content. Drug Discovery News or its sponsors may contact you to offer you content or products based on your interest in this topic. You may unsubscribe from these communications at any time. For information on how to unsubscribe, our privacy practices, and commitment to protecting your privacy, check out our Privacy Policy.

Topics to be covered Thursday, June 29th, 2023 | 1:30 PM - 4:00 PM Eastern Time Speakers Dawn Bowles, PhD Samira Kiani, MD, PhD David Schaffer, PhD Weidong Xiao, PhD